A weekly dose comparison of 5000 units of vitamin D supplementation with a daily dose of 4,000 units in patients with chronic leukemia

Comparing theVitamin-D level treatment with 50000IU weekly Vitamin D and 4000IU daily Vitamin-D in Chronic lymphocytic leukemia patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180912041010N1

Enrollment

Registered

2018-09-16

Start date

2018-10-31

Completion date

Unknown

Last updated

2018-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic lymphocytic leukemia. Other lymphoid leukaemia

Interventions

Intervention 1: Intervention group: Receive daily 4000 units vitamin D for 3 months. Intervention 2: Intervention group: Receive weeky 5000 vitamin D units for 3 months.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Chronic lymphocyte leukemia with a serum level of vitamin D of less than 30

Exclusion criteria

Exclusion criteria: Hepatic failure Renal failure Get Vitamin D supplementation in the last three months

Design outcomes

Primary

Measure	Time frame
Patient tolerance to the dose. Timepoint: 6 months after intervention. Method of measurement: Vitamin D Serum level in the blood sample.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmir Fallahnia

Qazvin University of Medical Sciences

drafallahnia@yahoo.com+98 28 3379 0620

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026